| UniProt ID | ECM1_HUMAN | |
|---|---|---|
| UniProt AC | Q16610 | |
| Protein Name | Extracellular matrix protein 1 | |
| Gene Name | ECM1 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 540 | |
| Subcellular Localization | Secreted, extracellular space, extracellular matrix. | |
| Protein Description | Involved in endochondral bone formation as negative regulator of bone mineralization. Stimulates the proliferation of endothelial cells and promotes angiogenesis. Inhibits MMP9 proteolytic activity.. | |
| Protein Sequence | MGTTARAALVLTYLAVASAASEGGFTATGQRQLRPEHFQEVGYAAPPSPPLSRSLPMDHPDSSQHGPPFEGQSQVQPPPSQEATPLQQEKLLPAQLPAEKEVGPPLPQEAVPLQKELPSLQHPNEQKEGTPAPFGDQSHPEPESWNAAQHCQQDRSQGGWGHRLDGFPPGRPSPDNLNQICLPNRQHVVYGPWNLPQSSYSHLTRQGETLNFLEIGYSRCCHCRSHTNRLECAKLVWEEAMSRFCEAEFSVKTRPHWCCTRQGEARFSCFQEEAPQPHYQLRACPSHQPDISSGLELPFPPGVPTLDNIKNICHLRRFRSVPRNLPATDPLQRELLALIQLEREFQRCCRQGNNHTCTWKAWEDTLDKYCDREYAVKTHHHLCCRHPPSPTRDECFARRAPYPNYDRDILTIDIGRVTPNLMGHLCGNQRVLTKHKHIPGLIHNMTARCCDLPFPEQACCAEEEKLTFINDLCGPRRNIWRDPALCCYLSPGDEQVNCFNINYLRNVALVSGDTENAKGQGEQGSTGGTNISSTSEPKEE | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 3 | Phosphorylation | -----MGTTARAALV -----CCHHHHHHHH | 18.91 | - | |
| 12 | Phosphorylation | ARAALVLTYLAVASA HHHHHHHHHHHHHHH | 14.71 | 23532336 | |
| 18 | Phosphorylation | LTYLAVASAASEGGF HHHHHHHHHHHHCCC | 20.12 | 24719451 | |
| 43 | Phosphorylation | EHFQEVGYAAPPSPP HHHHHCCCCCCCCCC | 12.55 | - | |
| 43 | O-linked_Glycosylation | EHFQEVGYAAPPSPP HHHHHCCCCCCCCCC | 12.55 | 30806347 | |
| 48 | Phosphorylation | VGYAAPPSPPLSRSL CCCCCCCCCCCCCCC | 37.78 | 26091039 | |
| 48 | O-linked_Glycosylation | VGYAAPPSPPLSRSL CCCCCCCCCCCCCCC | 37.78 | 55833179 | |
| 52 | Phosphorylation | APPSPPLSRSLPMDH CCCCCCCCCCCCCCC | 26.12 | 26091039 | |
| 63 | O-linked_Glycosylation | PMDHPDSSQHGPPFE CCCCCCHHHCCCCCC | 33.31 | OGP | |
| 80 | O-linked_Glycosylation | SQVQPPPSQEATPLQ CCCCCCCCCCCCCCC | 46.56 | OGP | |
| 80 | Phosphorylation | SQVQPPPSQEATPLQ CCCCCCCCCCCCCCC | 46.56 | 24505115 | |
| 84 | O-linked_Glycosylation | PPPSQEATPLQQEKL CCCCCCCCCCCHHHC | 24.63 | OGP | |
| 119 | O-linked_Glycosylation | PLQKELPSLQHPNEQ CHHHHCCCCCCCCCC | 53.97 | 55824565 | |
| 130 | O-linked_Glycosylation | PNEQKEGTPAPFGDQ CCCCCCCCCCCCCCC | 19.85 | OGP | |
| 138 | O-linked_Glycosylation | PAPFGDQSHPEPESW CCCCCCCCCCCCCCC | 45.83 | OGP | |
| 354 | N-linked_Glycosylation | RCCRQGNNHTCTWKA HHHHHCCCCCEEEHH | 38.37 | UniProtKB CARBOHYD | |
| 369 | Phosphorylation | WEDTLDKYCDREYAV HHHHHHHHHCHHHHH | 10.15 | 22468782 | |
| 374 | Phosphorylation | DKYCDREYAVKTHHH HHHHCHHHHHHCCCC | 20.00 | 22468782 | |
| 378 | Phosphorylation | DREYAVKTHHHLCCR CHHHHHHCCCCCCCC | 21.60 | 22468782 | |
| 391 | O-linked_Glycosylation | CRHPPSPTRDECFAR CCCCCCCCHHHHHHH | 55.90 | 55829579 | |
| 411 | Phosphorylation | NYDRDILTIDIGRVT CCCCCEEEEECCCCC | 19.55 | 24719451 | |
| 418 | Phosphorylation | TIDIGRVTPNLMGHL EEECCCCCCCHHHHH | 12.71 | - | |
| 433 | Phosphorylation | CGNQRVLTKHKHIPG HCCCHHHCCCCCCCC | 28.39 | - | |
| 438 | Phosphorylation | VLTKHKHIPGLIHNM HHCCCCCCCCHHHHC | 3.27 | 24719451 | |
| 444 | N-linked_Glycosylation | HIPGLIHNMTARCCD CCCCHHHHCCCHHCC | 23.62 | 17623646 | |
| 444 | N-linked_Glycosylation | HIPGLIHNMTARCCD CCCCHHHHCCCHHCC | 23.62 | 16335952 | |
| 530 | N-linked_Glycosylation | QGSTGGTNISSTSEP CCCCCCCCCCCCCCC | 35.11 | UniProtKB CARBOHYD | |
| 534 | O-linked_Glycosylation | GGTNISSTSEPKEE- CCCCCCCCCCCCCC- | 30.25 | OGP |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of ECM1_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of ECM1_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of ECM1_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| IRAK3_HUMAN | IRAK3 | physical | 21988832 | |
| CPTP_HUMAN | CPTP | physical | 21988832 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| 247100 | Lipoid proteinosis (LiP) | |||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| N-linked Glycosylation | |
| Reference | PubMed |
| "Human plasma N-glycoproteome analysis by immunoaffinity subtraction,hydrazide chemistry, and mass spectrometry."; Liu T., Qian W.-J., Gritsenko M.A., Camp D.G. II, Monroe M.E.,Moore R.J., Smith R.D.; J. Proteome Res. 4:2070-2080(2005). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-444, AND MASSSPECTROMETRY. | |